3rd International Conference on Multiple Myeloma

Chairs: Sagar Lonial, Mohamad Mohty, Antonio Palumbo

SESSION I: BIOLOGY

Cytogenetics and NGS – Hervé Avet-Loiseau
SNP, mutations and GEP – Pieter Sonneveld
Minimal residual disease – Bruno Paiva
Bone disease – Nicola Giuliani

SESSION II: BIOLOGY

Clonality – Nikhil Munshi
Immunity – Fabio Malavasi
Signalling pathways – Tuna Mutis

SESSION III: MYELOMA DIAGNOSIS AND STAGING (INCLUDING MGUS AND SMM)

When to treat – Sonja Zweegman
Imaging – Elena Zamagni
MGUS and smoldering myeloma – Maria-Victoria Mateos

Special lecture:
Drug development in myeloma – Sagar Lonial

SESSION IV: TREATMENT OF TRANSPLANT ELIGIBLE PATIENTS

Induction – Hermann Einsele
Consolidation – Michele Cavo
Allogeneic transplantation – Nicolaus Kröger

SESSION V: TREATMENT OF ELDERLY PATIENTS

Front line therapy for fit patients – Mohamad Mohty
Front line therapy for frail patients – Alessandra Larocca
Supportive care – Heinz Ludwig

SESSION VI: SPECIAL LECTURE

Cost-effectiveness analysis to inform health technology assessment considerations in haematological oncology – Andrea Manca

SESSION VII: TREATMENT OF RELAPSED PATIENTS

IMids – Jens Hillengass
Proteasome inhibitors – Thierry Facon
Monoclonal antibodies – Torben Plesner
How to sequence agents in RRMM – Philippe Moreau

SESSION VIII: AMYLOIDOSIS AND WALDENSTRÖM MACROGLOBULINEMIA

Waldenström – Steven Treon
Amyloidosis – Giampaolo Merlini